We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTD icon
3076
WisdomTree US Total Dividend Fund
DTD
$1.7B
$375K ﹤0.01%
6,484
-216
-3% -$13.3K
LCNB icon
3077
LCNB Corp
LCNB
$285M
$375K ﹤0.01%
25,083
+14,135
+129% +$229K
DNMR
3078
DELISTED
Danimer Scientific, Inc.
DNMR
$375K ﹤0.01%
2,055
+181
+10% +$32.9K
RVNU icon
3079
Xtrackers Municipal Infrastructure Revenue Bond Active ETF
RVNU
$144M
$374K ﹤0.01%
15,040
+200
+1% +$5.04K
VHI icon
3080
Valhi
VHI
$466M
$374K ﹤0.01%
8,255
-58,090
-88% -$2.31M
WTPI
3081
WisdomTree Equity Premium Income Fund
WTPI
$504M
$374K ﹤0.01%
11,697
FFBC icon
3082
First Financial Bancorp
FFBC
$3.6B
$373K ﹤0.01%
19,252
-1,553
-7% -$32.3K
OTEX icon
3083
Open Text
OTEX
$6.02B
$373K ﹤0.01%
9,851
+4,863
+97% +$193K
PXF icon
3084
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.98B
$372K ﹤0.01%
9,359
-2,611
-22% -$114K
METC icon
3085
Ramaco Resources Class A
METC
$667M
$371K ﹤0.01%
+29,122
New +$438K
MSD
3086
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$371K ﹤0.01%
56,115
-3,179
-5% -$22.9K
OIA icon
3087
Invesco Municipal Income Opportunities Trust
OIA
$292M
$371K ﹤0.01%
57,445
+6,657
+13% +$43.8K
TLTE icon
3088
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$352M
$370K ﹤0.01%
7,547
+147
+2% +$7.7K
CSTR
3089
DELISTED
CapStar Financial Holdings, Inc
CSTR
$370K ﹤0.01%
18,834
-2,815
-13% -$57.1K
CVI icon
3090
CVR Energy
CVI
$3.58B
$369K ﹤0.01%
+11,008
New +$351K
FMF icon
3091
First Trust Managed Futures Strategy Fund
FMF
$258M
$369K ﹤0.01%
7,153
-1,091
-13% -$56.3K
INSI
3092
DELISTED
Insight Select Income Fund
INSI
$369K ﹤0.01%
22,981
-2,007
-8% -$33.4K
NEU icon
3093
NewMarket
NEU
$8.72B
$368K ﹤0.01%
1,222
-59
-5% -$19.1K
ZUO
3094
DELISTED
Zuora, Inc.
ZUO
$368K ﹤0.01%
41,118
+3,906
+10% +$43.4K
GRX
3095
Gabelli Healthcare & Wellness Trust
GRX
$147M
$367K ﹤0.01%
34,248
-75,660
-69% -$877K
SCHL icon
3096
Scholastic
SCHL
$784M
$367K ﹤0.01%
10,201
+109
+1% +$4.03K
IXP icon
3097
iShares Global Comm Services ETF
IXP
$569M
$366K ﹤0.01%
5,990
+2,595
+76% +$172K
USPH icon
3098
US Physical Therapy
USPH
$1.24B
$366K ﹤0.01%
3,353
+548
+20% +$58.2K
BRW
3099
Saba Capital Income & Opportunities Fund
BRW
$335M
$365K ﹤0.01%
45,495
+1,255
+3% +$10.5K
KYNB
3100
Kyntra Bio
KYNB
$28.5M
$365K ﹤0.01%
1,383
+32
+2% +$8.18K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.